Novel Financing Mechanisms Needed To Improve Access To Multidrug-Resistant TB Treatment
PLOS Medicine: Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
Thomas Hwang of Harvard University and the Blackstone Group, and Salmaan Keshavjee of Harvard University and Partners in Health, explore issues surrounding scaling up access to treatment for multidrug-resistant tuberculosis, including novel financing structures (9/30).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.